06 Oct 2022
17:45 CEST |
ACTICOR BIOTECH |
Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of September 30, 2022
|
20103010 Biotechnology |
Other subject |
06 Oct 2022
17:45 CEST |
ACTICOR BIOTECH |
Acticor Biotech : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 30 septembre 2022
|
20103010 Biotechnology |
Other subject |
26 Sep 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech annonce le recrutement du premier patient aux États-Unis dans son étude de phase 2/3 ACTISAVE dans le traitement de l’AVC
|
20103010 Biotechnology |
Other subject |
26 Sep 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech Announces the Enrollment of the First US Patient in Its Phase 2/3 Study ACTISAVE for the Treatment of Stroke
|
20103010 Biotechnology |
Other subject |
23 Sep 2022
07:30 CEST |
ACTICOR BIOTECH |
Acticor Biotech annonce le report de la publication de ses résultats semestriels 2022
|
20103010 Biotechnology |
Meetings / events |
23 Sep 2022
07:30 CEST |
ACTICOR BIOTECH |
Acticor Biotech Postpones Release of Its 2022 Half-Year Financial Results
|
20103010 Biotechnology |
Meetings / events |
09 Sep 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 aout 2022
|
20103010 Biotechnology |
Other subject |
09 Sep 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of August 31, 2022
|
20103010 Biotechnology |
Other subject |
03 Aug 2022
18:30 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 juillet 2022
|
20103010 Biotechnology |
Other subject |
03 Aug 2022
18:30 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of July 31, 2022
|
20103010 Biotechnology |
Other subject |
21 Jul 2022
19:26 CEST |
ACTICOR BIOTECH |
Acticor Biotech obtains "PRIME" status from the European Medicines Agency for glenzocimab in the treatment of stroke
|
20103010 Biotechnology |
Products and services |
21 Jul 2022
19:26 CEST |
ACTICOR BIOTECH |
Acticor Biotech obtient le statut « PRIME » de l’Agence Européenne des Médicaments pour glenzocimab dans le traitement de l’AVC
|
20103010 Biotechnology |
Products and services |
11 Jul 2022
19:33 CEST |
ACTICOR BIOTECH |
Acticor Biotech: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
|
20103010 Biotechnology |
Other subject |
11 Jul 2022
19:33 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE KEPLER CHEUVREUX
|
20103010 Biotechnology |
Other subject |
11 Jul 2022
19:05 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of June 30, 2022
|
20103010 Biotechnology |
Other subject |
11 Jul 2022
19:05 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2022
|
20103010 Biotechnology |
Other subject |
29 Jun 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech Announces the Issuance of a Patent in Europe for Glenzocimab, Its Innovative Product for the Treatment of Cardiovascular Emergencies
|
20103010 Biotechnology |
Other subject |
29 Jun 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech annonce la délivrance d’un brevet en Europe portant sur glenzocimab, son produit innovant pour le traitement des urgences cardio-vasculaires
|
20103010 Biotechnology |
Other subject |
07 Jun 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 mai 2022
|
20103010 Biotechnology |
Other subject |
07 Jun 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech: Disclosure of the Total Number of Voting Rights and Shares as of May 31, 2022
|
20103010 Biotechnology |
Other subject |
09 May 2022
18:05 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Présentation des résultats positifs de l’étude de phase 1b/2a ACTIMIS dans le traitement de l’AVC à l’occasion de l’ESOC 2022
|
20103010 Biotechnology |
Meetings / events |
09 May 2022
18:05 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Presentation of Positive Results From the ACTIMIS Phase 1b/2a Study in Stroke at ESOC 2022
|
20103010 Biotechnology |
Meetings / events |
04 May 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 30 avril 2022
|
20103010 Biotechnology |
Other subject |
04 May 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of April 30, 2022
|
20103010 Biotechnology |
Other subject |
27 Apr 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Mise à disposition du Document d’enregistrement universel 2021 et des documents préparatoires relatifs à l’assemblée générale mixte du 12 mai 2022
|
20103010 Biotechnology |
Other subject |
27 Apr 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Availability of the 2021 Universal Registration Document and the Preparatory Documents for the Combined General Meeting of May 12, 2022
|
20103010 Biotechnology |
Other subject |
04 Apr 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of March 31, 2022
|
20103010 Biotechnology |
Other subject |
04 Apr 2022
18:00 CEST |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 mars 2022
|
20103010 Biotechnology |
Other subject |
30 Mar 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech Announces Its 2021 Full-year Financial Results and Gives an Update on Its Clinical Development
|
20103010 Biotechnology |
Income |
30 Mar 2022
18:00 CEST |
ACTICOR BIOTECH |
Acticor Biotech annonce ses résultats financiers annuels 2021 et fait le point sur son développement clinique
|
20103010 Biotechnology |
Income |
08 Mar 2022
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech Announces the Appointment of Corinne Le Goff to the Board of Directors as an Independent Director
|
20103010 Biotechnology |
Other subject |
08 Mar 2022
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech annonce la nomination au Conseil d’administration de Corinne Le Goff en qualité d’administratrice indépendante
|
20103010 Biotechnology |
Other subject |
03 Mar 2022
17:45 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of February 28, 2022
|
20103010 Biotechnology |
Other subject |
03 Mar 2022
17:45 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 28 février 2022
|
20103010 Biotechnology |
Other subject |
22 Feb 2022
08:00 CET |
ACTICOR BIOTECH |
Acticor Biotech annonce les résultats positifs de son étude de phase 1b/2a, ACTIMIS, chez les patients atteints d’accident vasculaire cérébral (AVC) ischémique aigu
|
20103010 Biotechnology |
Other subject |
22 Feb 2022
08:00 CET |
ACTICOR BIOTECH |
Acticor Biotech Announces Positive Results From Its ACTIMIS PHASE 1b/2a Study in Patients With Acute Ischemic Stroke (AIS)
|
20103010 Biotechnology |
Other subject |
07 Feb 2022
18:00 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 janvier 2022
|
20103010 Biotechnology |
Other subject |
07 Feb 2022
18:00 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares as of January 31, 2022
|
20103010 Biotechnology |
Other subject |
02 Feb 2022
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech : Résultats de l’étude de phase 2, GARDEN dans le syndrome de détresse respiratoire lié au Covid-19
|
20103010 Biotechnology |
Products and services |
02 Feb 2022
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech: Results of the Phase 2 GARDEN Study in COVID-19-Related Acute Respiratory Distress Syndrome
|
20103010 Biotechnology |
Products and services |
13 Jan 2022
18:00 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Half-year Report on the Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
|
20103010 Biotechnology |
Other subject |
13 Jan 2022
18:00 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE KEPLER CHEUVREUX
|
20103010 Biotechnology |
Other subject |
13 Jan 2022
18:00 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH: Disclosure of the Total Number of Voting Rights and Shares
|
20103010 Biotechnology |
Other subject |
13 Jan 2022
18:00 CET |
ACTICOR BIOTECH |
ACTICOR BIOTECH : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
|
20103010 Biotechnology |
Other subject |
12 Jan 2022
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech Announces Coverage of Its Stock by Gilbert Dupont and Kepler Cheuvreux
|
20103010 Biotechnology |
Other subject |
12 Jan 2022
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech annonce la couverture de son titre par Gilbert Dupont et Kepler Cheuvreux
|
20103010 Biotechnology |
Other subject |
16 Dec 2021
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech annonce son agenda financier 2022
|
20103010 Biotechnology |
Meetings / events |
16 Dec 2021
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech Announces Its 2022 Financial Agenda
|
20103010 Biotechnology |
Meetings / events |
07 Dec 2021
18:00 CET |
ACTICOR BIOTECH |
Acticor Biotech : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
|
20103010 Biotechnology |
Other subject |
04 Nov 2021
19:13 CET |
ACTICOR BIOTECH |
Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab in Acute Ischemic Stroke
|
20103010 Biotechnology |
Other subject |